Abstract:The gut–brain axis (GBA) plays a significant role in various neurodegenerative disorders, such as Alzheimer's disease (AD), and the gut microbiome (GM) can bidirectionally communicate with the brain through the GBA. Thus, recent evidence indicates that the GM may affect the pathological features and the progression of AD in humans. The aim of our study was to elucidate the impact of probiotics on the pathological features of AD in a 5xFAD model. Probiotics (Bifidobacterium lactis, Levilactobacillus brevis, and Limosilactobacillus fermentum) were orally administered in 5xFAD mice to modify the GM composition. Additionally, freeze-dried food containing phosphatidylserine was used as the positive control. Behavioral pathogenesis was assessed through the cross maze and Morris water maze tests. Our findings revealed that probiotic administration resulted in significant improvements in spatial and recognition memories. Furthermore, the neuroprotective effects of probiotics were substantiated by a reduction in amyloid-β accumulation in critical brain regions. Microglial activation in 5xFAD mice was also attenuated by probiotics in the hippocampus and cerebral cortex. Moreover, elevated tau phosphorylation in 5xFAD mice was ameliorated in the probiotics-treated group. The results highlight the potential use of probiotics as a neuroprotective intervention in AD.

What problem does this paper attempt to address?

### Problems the paper attempts to solve This paper aims to explore the effects of probiotics on the pathological features of Alzheimer's disease (AD) model mice. Specifically, the research team hopes to improve tau protein phosphorylation, amyloid - β protein (Aβ) accumulation, microglial cell activation and memory loss in 5xFAD mice (a commonly used AD model) by oral administration of probiotics. ### Background and motivation 1. **Pathological features of Alzheimer's disease**: - Alzheimer's disease is a chronic progressive neurodegenerative disease that mainly affects brain functions, including memory and cognition. - The core pathophysiological features include: the aggregation of hyperphosphorylated tau protein in neurons to form neurofibrillary tangles, and the intercellular aggregation of insoluble amyloid - β protein (Aβ) to form neuritic plaques. 2. **The role of the gut - brain axis**: - The gut - brain axis (GBA) plays an important role in various neurodegenerative diseases, especially Alzheimer's disease. - The gut microbiota (GM) can communicate bidirectionally with the brain through the GBA and affect the pathological features and progression of AD. 3. **The potential role of probiotics**: - Recent studies have shown that the intake of specific probiotics can improve various diseases, including sepsis, cancer and neurodegenerative diseases, through antioxidant and anti - inflammatory pathways. - Lactic acid bacteria (such as Lactobacillus and Bifidobacterium) are the most commonly used probiotics, and multiple studies have supported their role in improving cognitive function. ### Research methods 1. **Animal model**: - 4 - month - old 5xFAD mice were used as AD models. These mice carry APP and presenilin mutations and will develop amyloid plaques in the brain at 2 to 4 months of age. - The experiment was divided into four groups: 5xFAD control group, 5xFAD probiotic group, 5xFAD phosphatidylserine (PS) group and wild - type (WT) control group. 2. **Behavioral tests**: - Spatial memory and recognition memory of mice were evaluated by cross - maze and Morris water maze tests. - The results showed that 5xFAD mice treated with probiotics and PS showed significant improvement in memory tests. 3. **Immunohistochemical analysis**: - Aβ accumulation and microglial cell activation were detected by immunohistochemistry. - The results indicated that probiotic and PS treatment significantly reduced Aβ accumulation in the brains of 5xFAD mice and alleviated microglial cell activation. ### Main findings 1. **Probiotics improve memory function**: - Probiotic treatment significantly improved the spatial memory and recognition memory of 5xFAD mice. 2. **Reduce Aβ accumulation**: - Probiotic treatment significantly reduced Aβ accumulation in the hippocampus and cerebral cortex of 5xFAD mice. 3. **Inhibit microglial cell activation**: - Probiotic treatment significantly reduced the activation of microglial cells in the hippocampus and cerebral cortex of 5xFAD mice. ### Conclusion The results of this study suggest that probiotics can be a potential neuroprotective intervention for the treatment of Alzheimer's disease. By improving the gut microbiota, probiotics may help to alleviate the pathological features of AD, thereby improving the cognitive function of patients.

Oral Administration of Probiotic Bacteria Alleviates Tau Phosphorylation, Aβ Accumulation, Microglia Activation, and Memory Loss in 5xFAD Mice

Slowing Alzheimer's disease progression through probiotic supplementation

Chronic administration of prebiotics and probiotics ameliorates pathophysiological hallmarks of Alzheimer's disease in a APP/PS1 transgenic mouse model

Gut microbiota manipulation through probiotics oral administration restores glucose homeostasis in a mouse model of Alzheimer's disease

Bifidobacterium Lactis Probio-M8 regulates gut microbiota to alleviate Alzheimer’s disease in the APP/PS1 mouse model

Administration of Bifidobacterium breve Improves the Brain Function of Aβ1-42-Treated Mice via the Modulation of the Gut Microbiome

Probiotics as potential therapeutic options for Alzheimer's disease

Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer’s disease animal model

Multi-strain Probiotics Ameliorate Alzheimer’s-like Cognitive Impairment and Pathological Changes Through the AKT/GSK-3β Pathway in Senescence-Accelerated Mouse Prone 8 Mice

Probiotics as potential therapeutic options for Alzheimer’s disease

Transplantation of gut microbiota derived from Alzheimer's disease mouse model impairs memory function and neurogenesis in C57BL/6 mice

Probiotics Modulate the Microbiota–gut–brain Axis and Improve Memory Deficits in Aged SAMP8 Mice

Lactobacillus Plantarum DP189 Prevents Cognitive Dysfunction in D-galactose/AlCl3 Induced Mouse Model of Alzheimer’s Disease Via Modulating Gut Microbiota and PI3K/Akt/GSK-3β Signaling Pathway

Live and Heat-Inactivated Streptococcus thermophilus MN-ZLW-002 Mediate the Gut–Brain Axis, Alleviating Cognitive Dysfunction in APP/PS1 Mice

The preventive effects of probiotic Akkermansia muciniphila on D-galactose/AlCl3 mediated Alzheimer's disease-like rats

Probiotics Improve Cognitive Impairment by Decreasing Bacteria-Related Pattern Recognition Receptor-Mediated Inflammation in the Gut-Brain Axis of Mice

Inhibition of microfold cells ameliorates early pathological phenotypes by modulating microglial functions in Alzheimer's disease mouse model

Probiotics Improve Flora Alternation and Memory Deficits in Aged Mice

Assessment of Probiotics Mixture on Memory Function, Inflammation Markers, and Oxidative Stress in an Alzheimer's Disease Model of Rats

Impact of interval training with probiotic (L. plantarum / Bifidobacterium bifidum) on passive avoidance test, ChAT and BDNF in the hippocampus of rats with Alzheimer's disease

Whey Protein Hydrolysate Intervention Ameliorates Memory Deficits in APP/PS1 Mice: Unveiling Gut Microbe–short‐chain Fatty Acid–brain Axis